Immediate Impact
69 standout
Citing Papers
Regulation and metabolic functions of mTORC1 and mTORC2
2021 Standout
Overcoming cancer therapeutic bottleneck by drug repurposing
2020 Standout
Works of Lamar Eaton being referenced
A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer
2017
A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Lamar Eaton | 37 | 113 | 49 | 177 | 94 | 12 | 273 | |
| Qixia Han | 32 | 84 | 31 | 205 | 161 | 10 | 295 | |
| Daniel Herr | 14 | 127 | 77 | 142 | 55 | 14 | 321 | |
| Ben Fisher | 34 | 90 | 28 | 254 | 153 | 7 | 329 | |
| Carolin Nestle-Krämling | 71 | 100 | 10 | 163 | 77 | 14 | 256 | |
| Mária Gere | 22 | 113 | 15 | 191 | 147 | 13 | 330 | |
| W. Bradford Carter | 21 | 125 | 59 | 168 | 94 | 10 | 309 | |
| A. Mitchell | 25 | 146 | 42 | 140 | 97 | 14 | 288 | |
| Tobias Lekberg | 15 | 146 | 39 | 137 | 34 | 12 | 263 | |
| Bruna Salani Mota | 26 | 102 | 23 | 142 | 60 | 19 | 277 | |
| In Ae Park | 17 | 201 | 91 | 140 | 44 | 11 | 324 |
All Works
Loading papers...